United States Non-Heparin Anticoagulant Injectables Market Report 2016

Publisher Name :
Date: 09-Oct-2016
No. of pages: 123
Inquire Before Buying

Notes:

Sales, means the sales volume of Non-Heparin Anticoagulant Injectables

Revenue, means the sales value of Non-Heparin Anticoagulant Injectables

This report studies sales (consumption) of Non-Heparin Anticoagulant Injectables in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer, Inc. (US)

- Bayer Healthcare AG (Germany)

- GlaxoSmithKline Plc. (UK)

- Boehringer Ingelheim (Germany)

- Sanofi S.A. (France)

- Abbott India Limited (India)

- Aspen Holdings (South Africa)

- Bristol-Myers Squibb Company (US)

- Eisai Inc. (US)

- Mitsubishi Tanabe Pharma Corporation (Japan)

- Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Non-Heparin Anticoagulant Injectables in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Non-Heparin Anticoagulant Injectables Market Report 2016

Table of Contents
United States Non-Heparin Anticoagulant Injectables Market Report 2016
1 Non-Heparin Anticoagulant Injectables Overview
1.1 Product Overview and Scope of Non-Heparin Anticoagulant Injectables
1.2 Classification of Non-Heparin Anticoagulant Injectables
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Non-Heparin Anticoagulant Injectables
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Non-Heparin Anticoagulant Injectables (2011-2021)
1.4.1 United States Non-Heparin Anticoagulant Injectables Sales and Growth Rate (2011-2021)
1.4.2 United States Non-Heparin Anticoagulant Injectables Revenue and Growth Rate (2011-2021)
2 United States Non-Heparin Anticoagulant Injectables Competition by Manufacturers
2.1 United States Non-Heparin Anticoagulant Injectables Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Non-Heparin Anticoagulant Injectables Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Non-Heparin Anticoagulant Injectables Average Price by Manufactures (2015 and 2016)
2.4 Non-Heparin Anticoagulant Injectables Market Competitive Situation and Trends
2.4.1 Non-Heparin Anticoagulant Injectables Market Concentration Rate
2.4.2 Non-Heparin Anticoagulant Injectables Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Non-Heparin Anticoagulant Injectables Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Non-Heparin Anticoagulant Injectables Sales and Market Share by Type (2011-2016)
3.2 United States Non-Heparin Anticoagulant Injectables Revenue and Market Share by Type (2011-2016)
3.3 United States Non-Heparin Anticoagulant Injectables Price by Type (2011-2016)
3.4 United States Non-Heparin Anticoagulant Injectables Sales Growth Rate by Type (2011-2016)
4 United States Non-Heparin Anticoagulant Injectables Sales (Volume) by Application (2011-2016)
4.1 United States Non-Heparin Anticoagulant Injectables Sales and Market Share by Application (2011-2016)
4.2 United States Non-Heparin Anticoagulant Injectables Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Non-Heparin Anticoagulant Injectables Manufacturers Profiles/Analysis
5.1 Pfizer, Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Non-Heparin Anticoagulant Injectables Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer, Inc. (US) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
5.2.2 Non-Heparin Anticoagulant Injectables Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Bayer Healthcare AG (Germany) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
5.3.2 Non-Heparin Anticoagulant Injectables Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GlaxoSmithKline Plc. (UK) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
5.4.2 Non-Heparin Anticoagulant Injectables Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Boehringer Ingelheim (Germany) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
5.5.2 Non-Heparin Anticoagulant Injectables Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi S.A. (France) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
5.6.2 Non-Heparin Anticoagulant Injectables Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Abbott India Limited (India) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
5.7.2 Non-Heparin Anticoagulant Injectables Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Aspen Holdings (South Africa) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
5.8.2 Non-Heparin Anticoagulant Injectables Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bristol-Myers Squibb Company (US) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
5.9.2 Non-Heparin Anticoagulant Injectables Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Eisai Inc. (US) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
5.10.2 Non-Heparin Anticoagulant Injectables Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)
6 Non-Heparin Anticoagulant Injectables Manufacturing Cost Analysis
6.1 Non-Heparin Anticoagulant Injectables Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Non-Heparin Anticoagulant Injectables
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Non-Heparin Anticoagulant Injectables Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Non-Heparin Anticoagulant Injectables Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Non-Heparin Anticoagulant Injectables Market Forecast (2016-2021)
10.1 United States Non-Heparin Anticoagulant Injectables Sales, Revenue Forecast (2016-2021)
10.2 United States Non-Heparin Anticoagulant Injectables Sales Forecast by Type (2016-2021)
10.3 United States Non-Heparin Anticoagulant Injectables Sales Forecast by Application (2016-2021)
10.4 Non-Heparin Anticoagulant Injectables Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Non-Heparin Anticoagulant Injectables
Table Classification of Non-Heparin Anticoagulant Injectables
Figure United States Sales Market Share of Non-Heparin Anticoagulant Injectables by Type in 2015
Table Application of Non-Heparin Anticoagulant Injectables
Figure United States Sales Market Share of Non-Heparin Anticoagulant Injectables by Application in 2015
Figure United States Non-Heparin Anticoagulant Injectables Sales and Growth Rate (2011-2021)
Figure United States Non-Heparin Anticoagulant Injectables Revenue and Growth Rate (2011-2021)
Table United States Non-Heparin Anticoagulant Injectables Sales of Key Manufacturers (2015 and 2016)
Table United States Non-Heparin Anticoagulant Injectables Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Non-Heparin Anticoagulant Injectables Sales Share by Manufacturers
Figure 2016 Non-Heparin Anticoagulant Injectables Sales Share by Manufacturers
Table United States Non-Heparin Anticoagulant Injectables Revenue by Manufacturers (2015 and 2016)
Table United States Non-Heparin Anticoagulant Injectables Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Non-Heparin Anticoagulant Injectables Revenue Share by Manufacturers
Table 2016 United States Non-Heparin Anticoagulant Injectables Revenue Share by Manufacturers
Table United States Market Non-Heparin Anticoagulant Injectables Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Non-Heparin Anticoagulant Injectables Average Price of Key Manufacturers in 2015
Figure Non-Heparin Anticoagulant Injectables Market Share of Top 3 Manufacturers
Figure Non-Heparin Anticoagulant Injectables Market Share of Top 5 Manufacturers
Table United States Non-Heparin Anticoagulant Injectables Sales by Type (2011-2016)
Table United States Non-Heparin Anticoagulant Injectables Sales Share by Type (2011-2016)
Figure United States Non-Heparin Anticoagulant Injectables Sales Market Share by Type in 2015
Table United States Non-Heparin Anticoagulant Injectables Revenue and Market Share by Type (2011-2016)
Table United States Non-Heparin Anticoagulant Injectables Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Non-Heparin Anticoagulant Injectables by Type (2011-2016)
Table United States Non-Heparin Anticoagulant Injectables Price by Type (2011-2016)
Figure United States Non-Heparin Anticoagulant Injectables Sales Growth Rate by Type (2011-2016)
Table United States Non-Heparin Anticoagulant Injectables Sales by Application (2011-2016)
Table United States Non-Heparin Anticoagulant Injectables Sales Market Share by Application (2011-2016)
Figure United States Non-Heparin Anticoagulant Injectables Sales Market Share by Application in 2015
Table United States Non-Heparin Anticoagulant Injectables Sales Growth Rate by Application (2011-2016)
Figure United States Non-Heparin Anticoagulant Injectables Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Non-Heparin Anticoagulant Injectables Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Non-Heparin Anticoagulant Injectables Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Non-Heparin Anticoagulant Injectables Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Non-Heparin Anticoagulant Injectables Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Non-Heparin Anticoagulant Injectables Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Non-Heparin Anticoagulant Injectables Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Non-Heparin Anticoagulant Injectables Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Non-Heparin Anticoagulant Injectables Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Non-Heparin Anticoagulant Injectables Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Non-Heparin Anticoagulant Injectables Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Non-Heparin Anticoagulant Injectables Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Non-Heparin Anticoagulant Injectables Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-Heparin Anticoagulant Injectables
Figure Manufacturing Process Analysis of Non-Heparin Anticoagulant Injectables
Figure Non-Heparin Anticoagulant Injectables Industrial Chain Analysis
Table Raw Materials Sources of Non-Heparin Anticoagulant Injectables Major Manufacturers in 2015
Table Major Buyers of Non-Heparin Anticoagulant Injectables
Table Distributors/Traders List
Figure United States Non-Heparin Anticoagulant Injectables Production and Growth Rate Forecast (2016-2021)
Figure United States Non-Heparin Anticoagulant Injectables Revenue and Growth Rate Forecast (2016-2021)
Table United States Non-Heparin Anticoagulant Injectables Production Forecast by Type (2016-2021)
Table United States Non-Heparin Anticoagulant Injectables Consumption Forecast by Application (2016-2021)
  • Global Drug-eluting Stents Sales Market Report 2016
    Published: 09-Dec-2016        Price: US 4000 Onwards        Pages: 107
    Notes: Sales, means the sales volume of Drug-Eluting Stents Revenue, means the sales value of Drug-Eluting Stents This report studies sales (consumption) of Drug-Eluting Stents in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Abbott Vascular (USA) - Boston Scientific, Inc. (USA) - Biosenso......
  • United States, EU, Japan, China, India and Southeast Asia Extracorporeal Shock Wave Lithotripsy Market Size, Status and Forecast 2021
    Published: 09-Dec-2016        Price: US 3300 Onwards        Pages: 113
    Notes: Production, means the output of Extracorporeal Shock Wave Lithotripsy Revenue, means the sales value of Extracorporeal Shock Wave Lithotripsy This report studies the global Extracorporeal Shock Wave Lithotripsy market, analyzes and researches the Extracorporeal Shock Wave Lithotripsy development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Dornier ......
  • United States, EU, Japan, China, India and Southeast Asia Pregnancy Test Market Size, Status and Forecast 2021
    Published: 09-Dec-2016        Price: US 3300 Onwards        Pages: 99
    Notes: Production, means the output of Pregnancy Test Revenue, means the sales value of Pregnancy Test This report studies the global Pregnancy Test market, analyzes and researches the Pregnancy Test development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Clearblue - Alere (Acon Labs) - Quidel - First Response - E.p.t. - Nant......
  • Global Dental Membrane Market Research Report 2016
    Published: 09-Dec-2016        Price: US 2900 Onwards        Pages: 108
    Notes: Production, means the output of Dental Membrane Revenue, means the sales value of Dental Membrane This report studies Dental Membrane in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Geistlich Pharma AG - Zimmer Biomet - Integra LifeSciences Holdings Corporation......
  • Global Latex Medical Disposables Market Research Report 2016
    Published: 09-Dec-2016        Price: US 2900 Onwards        Pages: 101
    Notes: Production, means the output of Latex Medical Disposables Revenue, means the sales value of Latex Medical Disposables This report studies Latex Medical Disposables in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Ansell - Top Glove Corporation - Hartalega Holdings Be......
  • Global Ankle Splints Market Professional Survey Report 2016
    Published: 09-Dec-2016        Price: US 3500 Onwards        Pages: 103
    Notes: Production, means the output of Ankle Splints Revenue, means the sales value of Ankle Splints This report studies Ankle Splints in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share fo......
  • Global Asthma Treatment Drugs Market Professional Survey Report 2016
    Published: 09-Dec-2016        Price: US 3500 Onwards        Pages: 103
    Notes: Production, means the output of Asthma Treatment Drugs Revenue, means the sales value of Asthma Treatment Drugs This report studies Asthma Treatment Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, ......
  • Global Dental Implant Wrenches Sales Market Report 2016
    Published: 09-Dec-2016        Price: US 4000 Onwards        Pages: 101
    Notes: Sales, means the sales volume of Dental Implant Wrenches Revenue, means the sales value of Dental Implant Wrenches This report studies sales (consumption) of Dental Implant Wrenches in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - ISOMED S.r.L - Noris Medical - Surcam Medical Device......
  • Global Dental Materials for Dental Bridges Sales Market Report 2016
    Published: 09-Dec-2016        Price: US 4000 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Dental Materials for Dental Bridges Revenue, means the sales value of Dental Materials for Dental Bridges This report studies sales (consumption) of Dental Materials for Dental Bridges in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Amann Girrbach - DATRON......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs